The Result of Bone Grafting for Fibrous Dysplasia.
10.5292/jkbjts.2014.20.2.74
- Author:
Won Ju JEONG
1
;
Tae Seong KIM
;
Hwan Seong CHO
;
Jong Pil YOON
;
Il Hyung PARK
Author Information
1. Department of Orthopedic Surgery, Kyungpook National University Hospital, Daegu, Korea. ihpark@knu.ac.kr
- Publication Type:Original Article
- Keywords:
fibrous dysplasia;
autogenous bone graft;
recurrence
- MeSH:
Aneurysm;
Bone Cysts;
Bone Transplantation*;
Congenital Abnormalities;
Curettage;
Female;
Follow-Up Studies;
Fractures, Spontaneous;
GTP-Binding Proteins;
Humans;
Male;
Recurrence;
Reoperation;
Transplants
- From:The Journal of the Korean Bone and Joint Tumor Society
2014;20(2):74-79
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Fibrous dysplasia is related to the mutation of gene encoding the alpha-subunit of a signal-transducing G-protein and has variable clinical course. Operation can be performed to prevent functional disorder or structural deformity. After curettage, autologous bone graft were used to fill the defects after curettage. The aim of this study is to compare the result of autogenous cancellous bone grafting and allogenic bone grafting for fibrous dysplasia. MATERIALS AND METHODS: Among the patients who visit our hospital during the period of April, 1997 to October, 2013, we selected 34 patients who diagnosed fibrous dysplasia and visited our clinic over 1 year. There were 13 males and 21 females. Average age was 26.4 (range 2 to 57) years old. Autogenous bone graft (group I) in 5 cases, Non-autogenous bone graft (group II) in 30 cases. Iliac bone is used in all cases of autogenous bone graft. There were no significant difference in age, follow-up period, preoperational laboratory finding between two groups. Radiographic image was done to evaluate the recurrence of fibrous dysplasia or secondary degeneration. RESULTS: There were four cases in recurrence (group I: 1 case, group II: 3 cases, p=0.554). In all recurrent cases, reoperations were done using curettage and autogenous iliac bone graft. There was no re-recurrence after reoperation. One case of secondary aneurysmal bone cyst was confirmed (group II) and 1 cases of pathologic fractures had developed (group I: 0 case, group II: 1 cases, p=0.559). No malignant change occurred. CONCLUSION: There were no significant difference between autogenous bone graft group and non-autogenous bone graft group. Our result suggested that autogenous bone graft seems to be good method to treat fibrous dysplasia, in the case of small volume of tumor lesion or non-weight bearing portion.
